0
0
Home » Pharmaceuticals

Atopic Dermatitis (Atopic Eczema) – Global Clinical Trials Review, 2022

The global atopic dermatitis (atopic eczema) clinical trials review report H2 2021 provides an overview of atopic dermatitis clinical trials scenario. This report provides top-line data relating to the clinical trials on atopic dermatitis. The report also includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. Moreover, the report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. Additionally, the report provides prominent drugs for in-progress trials (based on the number of ongoing trials).

What are the market dynamics of the global atopic dermatitis clinical trials market?

The number of atopic dermatitis clinical trials conducted globally, has increased for the period 2017-2020. The average number of patients enrolled was highest in the year 2018. More than 20% of trials have been sponsored by institutions and over 60% by companies.

Dupilumab alone or in combination has the highest number of ongoing atopic dermatitis (atopic eczema) clinical trials.

What are the top regions and countries in the global atopic dermatitis clinical trials market?

In total, more than 1,700 clinical trials were conducted on atopic eczema, as of February 2022. Among these trials, over 600 clinical trials were conducted in Asia-Pacific.

Atopic dermatitis clinical trials market in Asia-Pacific

In the Asia-Pacific region, Japan has the highest number of atopic dermatitis clinical trials followed by China, South Korea, Australia, and India.

Atopic dermatitis clinical trials market in Europe

Among the European countries, Germany has the highest number of atopic dermatitis clinical trials, followed by the UK, Poland, Spain, and France.

Atopic dermatitis clinical trials market in North America

In the country-wise analysis, the US has the highest number of atopic dermatitis clinical trials in North America followed by Canada and Mexico.

Atopic dermatitis clinical trials market in the Middle East & Africa

Iran has the highest number of atopic dermatitis clinical trials followed by Israel, South Africa, Egypt, and Morocco.

Atopic dermatitis clinical trials market in Central & South America

Brazil has the highest number of atopic dermatitis clinical trials in the region followed by Argentina, Chile, Peru, and Colombia.

Atopic dermatitis clinical trials market in G7 countries

Among the G7 (the US, the UK, Germany, France, Italy, Canada, and Japan) countries, Canada has the highest proportion of atopic dermatitis to dermatology clinical trials as of February 2022. In total, more than 1,300 clinical trials were conducted on atopic dermatitis (atopic eczema) in G7 countries, of which over 450 clinical trials were in the US.

Atopic dermatitis clinical trials market in E7 countries

Among the E7 (Brazil, Russia, India, China, Mexico, Turkey, and Indonesia) countries, Mexico has the highest proportion of atopic dermatitis to dermatology clinical trials as of February 2022. In total, more than 280 clinical trials were conducted on atopic dermatitis in E7 Countries, of which over 140 clinical trials were conducted in China.

Global atopic dermatitis clinical trials market, by region

Global atopic dermatitis clinical trials market, by region

For more regional insights, download a free report sample

What is the phase-wise outlook of the global atopic dermatitis therapeutics clinical trials market?

As of February 2022, more than 700 clinical trials are in Phase II, of which over 100 clinical trials were in progress for the period of 1995-2022. During the same period, more than 270 clinical trials were in progress. The trials that were terminated/suspended or withdrawn accounted for more than 180. This was due to the lack of efficacy, safety, and lack of accrual of subjects.

Global atopic dermatitis clinical trials market, by phase

Global atopic dermatitis clinical trials market, by phase

For more phase insights, download a free report sample

Who are the key sponsors in the global atopic dermatitis clinical trials market?

The key sponsors in atopic dermatitis clinical trials sector are Novartis AG, LEO Foundation, Pfizer Inc, Sanofi, Regeneron Pharmaceuticals Inc, Eli Lilly and Co, GlaxoSmithKline Plc, Johnson & Johnson, Astellas Pharma Inc, and Galderma SA.

Global atopic dermatitis clinical trials sector, by key sponsors

Global atopic dermatitis clinical trials sector, by key sponsors

To know more about key sponsors, download a free report sample

Market report scope

Key regions Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America
Key sponsors Novartis AG, LEO Foundation, Pfizer Inc, Sanofi, Regeneron Pharmaceuticals Inc, Eli Lilly and Co, GlaxoSmithKline Plc, Johnson & Johnson, Astellas Pharma Inc, and Galderma SA

 Scope

  • The report provides a snapshot of the global clinical trials landscape
  • The report provides top-level data related to the clinical trials by region, country (G7 & E7), trial status, trial phase, sponsor type, and endpoint status
  • The report reviews top companies involved and enlists all trials (trial title, phase, and status) about the company
  • The report provides all the unaccomplished trials (terminated, suspended, and withdrawn) with the reason for unaccomplishment
  • The report provides enrollment trends for the past five years
  • The report provides the latest news for the past three months

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of global clinical trials market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in the global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended, or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional, and country-level

Key Players

Novartis AG

Pfizer Inc

Sanofi

Regeneron Pharmaceuticals Inc

LEO Foundation

Eli Lilly and Co

GlaxoSmithKline Plc

Johnson & Johnson

Astellas Pharma Inc

Galderma SA

Table of Contents

Table of Contents

Report Guidance

GlobalData Clinical Trials Report Coverage

Clinical Trials by Region

Clinical Trials and Average Enrollment by Country

Top Five Countries Contributing to Clinical Trials in Asia-Pacific

Top Five Countries Contributing to Clinical Trials in Europe

Top Countries Contributing to Clinical Trials in North America

Top Five Countries Contributing to Clinical Trials in Middle East and Africa

Top Five Countries Contributing to Clinical Trials in Central and South America

Clinical Trials by G7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials

Clinical Trials by Phase in G7 Countries

Clinical Trials in G7 Countries by Trial Status

Clinical Trials by E7 Countries: Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials

Clinical Trials by Phase in E7 Countries

Clinical Trials in E7 Countries by Trial Status

Clinical Trials by Phase

In Progress Trials by Phase

Clinical Trials by Trial Status

Clinical Trials by End Point Status

Subjects Recruited Over a Period of Time

Clinical Trials by Sponsor Type

Prominent Sponsors

Top Companies Participating in Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials

Prominent Drugs

Clinical Trial Profile Snapshots

Appendix

Abbreviations

Definitions

Research Methodology

Secondary Research

About GlobalData

Contact Us

Source

List of Tables

List of Tables

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2022*

Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

List of Figures

List of Figures

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Region (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, North America, Top Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2022*

Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, G7 Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2022*

Proportion of Atopic Dermatitis (Atopic Eczema) to Dermatology Clinical Trials, E7 Countries (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Phase (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials In Progress by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics, Global, Clinical Trials by Trial Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, by End Point Status, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2017-2021

Atopic Dermatitis (Atopic Eczema) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Key Sponsors, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2022*

Atopic Dermatitis (Atopic Eczema) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2022*

GlobalData Methodology

Frequently Asked Questions

The key regions in the global atopic dermatitis therapeutics clinical trials market are Asia-Pacific, Europe, North America, Middle East & Africa, and Central & South America.

The key companies in the global atopic dermatitis clinical trials sector are Novartis AG, LEO Foundation, Pfizer Inc, Sanofi, Regeneron Pharmaceuticals Inc, Eli Lilly, and Co, GlaxoSmithKline Plc, Johnson & Johnson, Astellas Pharma Inc, and Galderma SA.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports